Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease 05/03/2021 14:52 Schreiber et.al.; Gastroenterology 2021;160:2340–2353 קרא עוד ←
